Ophthalmology in Bridgeport, CT
10 verified ophthalmology doctors in Bridgeport.
Ophthalmologists are physicians who provide complete eye care, including surgery for eye disease.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Edward Pulice, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Delia Manjoney, MD
Ophthalmology
CMS Open Payments· $22.95 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$22.95
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total is on the lower end — around the 43th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Delia Manjoney do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jeffrey Kaplan, MD
Ophthalmology
CMS Open Payments· $363.22 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$363.22
Total received
14
Transactions
2
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 71th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Jeffrey Kaplan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anthony Masi, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jeffrey Sandler, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Reuven Rudich, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Anitha Patel, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Scott Seo, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Flora Levin, MD
Ophthalmology
CMS Open Payments· $84.03 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$84.03
Total received
4
Transactions
2
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 50th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Flora Levin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Marcio Abreu, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.